Infusion Extenders per NC of Ukraine EZS DK 021-2015: 33140000-3 Medical Supplies (NC 024:2023: 44685 Connecting tube for contrast agent administration; 12170 Extension set for intravenous infusions; NC 031:2024 A03020102 - High-pressure extension tubes; A03020101 Low-pressure extension tubes)

The Communal Non-Profit Enterprise "Odesa Regional Clinical Oncology Center" is procuring infusion extenders, classified under CPV code 33141300-3 (Puncturing and blood-taking apparatus), falling under the broader medical supplies category (CPV 33140000-3). The tender specifies various types of infusion extenders, including those for contrast agent administration, extension sets for intravenous infusions, and both high-pressure and low-pressure extension tubes. The delivery is to be made within 5 working days of receiving an order at the specified address in Odesa until December 31, 2026. A crucial condition is that the country of origin must not be the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. These medical devices are essential for administering fluids, medications, and contrast agents during medical procedures, particularly in oncology treatment. The procurement aims to ensure a continuous supply of these critical consumables for patient care at the Odesa Regional Clinical Oncology Center.

This is a supplies contract in the health and medical services sector, with a focus on Medical Equipment. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 456,000.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.